CRISPR Stocks List

Related ETFs - A few ETFs which own one or more of the above listed CRISPR stocks.

CRISPR Stocks Recent News

Date Stock Title
Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
Nov 20 CVAC Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?
Nov 20 CRSP CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?
Nov 20 EDIT Editas Medicine, Inc. (EDIT) Presents at Stifel 2024 Healthcare Conference (Transcript)
Nov 20 CRSP CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now
Nov 19 CVAC Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?
Nov 19 NTLA Intellia Therapeutics Announces Promising CRISPR Therapy Results
Nov 19 NTLA ReCode to secure funds for cystic fibrosis gene correction treatments
Nov 19 NTLA Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo
Nov 19 ABEO ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50…
Nov 19 NTLA Intellia Therapeutics' Gene Therapies Fall Short Of Breakthroughs (Rating Downgrade)
Nov 18 MGX What Makes Metagenomi (MGX) a New Buy Stock
Nov 18 NTLA Intellia’s gene editing therapy shows early potential in rare heart condition
Nov 18 CRSP CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
Nov 18 NTLA CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
Nov 17 CRSP CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024
Nov 16 NTLA Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
Nov 16 CRSP 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
Nov 15 CRSP CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)
Nov 15 MGX Metagenomi Third Quarter 2024 Earnings: US$0.51 loss per share (vs US$3.33 loss in 3Q 2023)
CRISPR

CRISPR () (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.Cas9 (or "CRISPR-associated 9") is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases..

The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages that provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA. Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.

Browse All Tags